Benno Schwikowski
Overview
Explore the profile of Benno Schwikowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
26640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Firoozbakht F, Yousefi B, Tsoy O, Baumbach J, Schwikowski B
Sci Rep
. 2024 Dec;
14(1):30885.
PMID: 39730699
Personalized medicine aims to tailor medical treatments to individual patients, and predicting drug responses from molecular profiles using machine learning is crucial for this goal. However, the high dimensionality of...
2.
Boudjeniba C, Soret P, Trutschel D, Hamon A, Baloche V, Chassagnol B, et al.
Clin Immunol
. 2024 May;
264:110241.
PMID: 38735508
Primary Sjögren disease (pSD) is an autoimmune disease characterized by lymphoid infiltration of exocrine glands leading to dryness of the mucosal surfaces and by the production of autoantibodies. The pathophysiology...
3.
Yousefi B, Firoozbakht F, Melograna F, Schwikowski B, Van Steen K
Front Genet
. 2023 Nov;
14:1274637.
PMID: 37928248
Molecular profiling technologies, such as RNA sequencing, offer new opportunities to better discover and understand the molecular networks involved in complex biological processes. Clinically important variations of diseases, or responses...
4.
Lobentanzer S, Aloy P, Baumbach J, Bohar B, Carey V, Charoentong P, et al.
Nat Biotechnol
. 2023 Jun;
41(8):1056-1059.
PMID: 37337100
No abstract available.
5.
Yousefi B, Melograna F, Galazzo G, van Best N, Mommers M, Penders J, et al.
Front Microbiol
. 2023 May;
14:1170391.
PMID: 37256048
Longitudinal analysis of multivariate individual-specific microbiome profiles over time or across conditions remains dauntin. Most statistical tools and methods that are available to study microbiomes are based on cross-sectional data....
6.
Felten R, Ye T, Schleiss C, Schwikowski B, Sibilia J, Monneaux F, et al.
Rheumatology (Oxford)
. 2023 Mar;
62(11):3715-3723.
PMID: 36869684
Objectives: To date, no immunomodulatory drug has demonstrated its efficacy in primary SS (pSS). We sought to analyse potential commonalities between pSS transcriptomic signatures and signatures of various drugs or...
7.
Kenigsbuch M, Bost P, Halevi S, Chang Y, Chen S, Ma Q, et al.
Nat Neurosci
. 2023 Jan;
26(3):528.
PMID: 36721022
No abstract available.
8.
Kenigsbuch M, Bost P, Halevi S, Chang Y, Chen S, Ma Q, et al.
Nat Neurosci
. 2022 Jun;
25(7):876-886.
PMID: 35760863
Alzheimer's disease (AD) is a complex neurodegenerative disease, perturbing neuronal and non-neuronal cell populations. In this study, using single-cell transcriptomics, we mapped all non-immune, non-neuronal cell populations in wild-type and...
9.
Trutschel D, Bost P, Mariette X, Bondet V, Llibre A, Posseme C, et al.
Arthritis Rheumatol
. 2022 Jun;
74(12):1991-2002.
PMID: 35726083
Objective: Primary Sjögren's syndrome (SS) is the second most frequent systemic autoimmune disease, affecting 0.1% of the general population. To characterize the molecular and clinical variabilities among patients with primary...
10.
Firoozbakht F, Yousefi B, Schwikowski B
Brief Bioinform
. 2021 Oct;
23(1).
PMID: 34619752
For an increasing number of preclinical samples, both detailed molecular profiles and their responses to various drugs are becoming available. Efforts to understand, and predict, drug responses in a data-driven...